Primary Mediastinal (Thymic) Large B-cell Lymphoma
7 clinical trials · Condition
◉ Watch Primary Mediastinal (Thymic) Large B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma (NCT04257578) | University of Washington | 2020-12-02 |
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma (NCT03704714) | Northwestern University | 2018-11-20 |
| Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03210662) | M.D. Anderson Cancer Center | 2018-02-01 |
| Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL (NCT02747732) | Meirav Kedmi MD | 2016-12-01 |
| Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies (NCT01760226) | Baylor College of Medicine | 2013-01-01 |
Track Primary Mediastinal (Thymic) Large B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.